lkpharm
- Biotech or pharma, therapeutic R&D
Shanghai Longke Pharmaceutical Co., Ltd. was established in August 2024 by Tonghua Dongbao Pharmaceutical Co., Ltd (SH: 600867) and Tonghua Shengnuo, with the vision of improving patients' health and life quality, and meeting the medical needs. The Management team and R&D team have the rich experience in Drug Research and Development, Management, and Industrialization throughout the life-cycle from Project Initiation to Market Launch, with over 10 innovative drug varieties having been launched in the past. The company's mission is to drive the innovation and create a world brand, always driven by the patient needs. We aim to develop the cutting-edge, breakthrough, disruptive, and curative drugs, from China to globe.
上海隆棵药业有限公司是由通化东宝（600867）和通化盛诺于2024年8月成立，以守护患者生活健康，提升患者生存质量，满足患者用药需求为目标。管理团队及研发团拥有从立项到上市的全生命周期的药物研发、管理及产业化经验，过往经历上市创新药品种超10个。公司以“坚持自主创新，创造世界品牌”为办企宗旨，始终以患者为中心，希望能通过几年努力研发出有前沿性、突破性、颠覆性、治愈性的药品，代表中国走向世界。
Address
ShanghaiShanghai
China
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}